Matrix Metalloproteinase Dynamics in Hepatic Fibrosis

Hepatic fibrosis is the consequence of chronic liver injury characterised by an imbalance between deposition and degradation of extracellular matrix (ECM), leading to scar formation and progression to cirrhosis. Matrix metalloproteinases (MMPs) are a family of zinc-dependent proteases that degrade ECM components, while tissue inhibitors of metalloproteinases (TIMPs) regulate MMP activity to maintain homeostasis. Dynamics of MMP and TIMP expression underpin the fibrogenic response orchestrated by hepatic stellate cells (HSCs), which become activated and produce type I and III collagens. Mechanical properties of the matrix, inflammatory cytokines and growth factors such as transforming growth factor-β (TGF-β), and cellular cross-talk with immune cells all modulate the MMP/TIMP balance. Dysregulation of this axis contributes to persistent fibrosis and impedes matrix resolution. Understanding the spatial and temporal patterns of MMP and TIMP activity has global significance for developing biomarkers and therapeutic strategies aimed at restoring ECM integrity and reversing fibrotic progression.

Research from Nature Portfolio

Studies have elucidated how mechanical cues within the fibrotic milieu influence MMP/TIMP secretion by activated HSCs. Investigations employing substrates of varying stiffness demonstrate that rigid environments downregulate MMP-9 expression and augment TIMP-1 release, creating a mechanical feedback loop that perpetuates matrix accumulation. In parallel, genetic ablation of key inhibitors has revealed redundancy within the MMP/TIMP network; mice deficient in TIMP-1 still develop significant fibrosis and hepatocarcinogenesis, indicating compensatory pathways that sustain ECM deposition. These findings underscore the necessity of multi-target approaches to modulate matrix turnover and interrupt fibrotic inertia.

Matrix Metalloproteinase Dynamics in Hepatic Fibrosis publication trend

The graph below shows the total number of articles in matrix metalloproteinase dynamics in hepatic fibrosis across all publications each year (not limited to Nature Index journals).

Technical terms

Extracellular matrix (ECM): Network of proteins and glycoproteins that provides structural support and regulates cell behaviour in tissues.

Hepatic stellate cells (HSCs): Liver pericytes that transdifferentiate into myofibroblast-like cells producing ECM during injury.

Matrix metalloproteinases (MMPs): Zinc-dependent endopeptidases responsible for ECM protein degradation and remodelling.

Tissue inhibitors of metalloproteinases (TIMPs): Endogenous proteins that bind MMPs to inhibit their proteolytic activity.

Transforming growth factor-β (TGF-β): Cytokine that promotes HSC activation and collagen synthesis.

References

1. Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis. Biomedicine & Pharmacotherapy (2023).
2. Concentration-Dependent Attenuation of Pro-Fibrotic Responses after Cannabigerol Exposure in Primary Rat Hepatocytes Cultured in Palmitate and Fructose Media. Cells (2023).
3. Evaluation of the Diagnostic Utility of Selected Serum Adipokines and Cytokines in Subjects with MASLD—A Pilot Study. Nutrients (2024).
4. Matrix stiffness modulates the activity of MMP-9 and TIMP-1 in hepatic stellate cells to perpetuate fibrosis. Scientific Reports (2019).
5. TIMP-1 is upregulated, but not essential in hepatic fibrogenesis and carcinogenesis in mice. Scientific Reports (2017).
6. Matrix Metalloproteinases as Potential Biomarkers and Therapeutic Targets in Liver Diseases. Cells (2020).